Prelude Therapeutics Incorporated Share Price
PRLDPrelude Therapeutics Incorporated Stock Performance
Open $3.99 | Prev. Close $3.86 | Circuit Range N/A |
Day Range $3.77 - $3.99 | Year Range $0.76 - $5.54 | Volume 9,194 |
Average Traded $3.94 |
Prelude Therapeutics Incorporated Share Price Chart
About Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Prelude Therapeutics Incorporated Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $3.99 | $3.96 | +0.00% |
09-Jun-26 | $3.99 | $3.96 | +2.46% |
08-Jun-26 | $3.88 | $3.86 | +1.31% |
05-Jun-26 | $3.94 | $3.81 | -6.73% |
04-Jun-26 | $3.62 | $4.08 | +9.81% |
03-Jun-26 | $3.49 | $3.72 | +6.13% |
02-Jun-26 | $3.67 | $3.50 | -8.49% |
FAQs on Prelude Therapeutics Incorporated Share Price
Can I buy Prelude Therapeutics Incorporated shares in India?
What is the share price of Prelude Therapeutics Incorporated?
What is the 5 year returns of Prelude Therapeutics Incorporated?
What are the high & low stock price of Prelude Therapeutics Incorporated today?
What is the 52-week high and low of Prelude Therapeutics Incorporated stock?